What Semnur Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 1 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 7,034,737 |
| Net activity | +0 | −7,034,737 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Scilex Holding Co | 10% owner | Jun 15 | Other Transaction · J | −7,034,737 | — | — | 174,770,112 |
| Scilex Holding Co | 10% owner | Sep 23 | Open-market sale · S | −554,849 | $16.00 | −$8.88M | 500,000 |
| Scilex Holding Co | 10% owner | Sep 23 | Open-market sale · S | −11,945,151 | $16.00 | −$191M | 181,804,849 |
| Denali Capital Global Investments Llc | 10% owner | Apr 11 | Open-market buy · P | +510,000 | $10.00 | +$5.1M | 510,000 |
| Xu Jiandong | 10% owner | Apr 11 | Open-market buy · P | +510,000 | $10.00 | +$5.1M | 510,000 |
Loading...
